
iollo
iollo is a YC Summer 2022 (S22) company. Based in San Francisco, CA, USA. Team of 4.
About iollo
Summary
iollo builds Quinn, an AI scientist for pharmaceutical and biotech R&D teams. Quinn runs the full drug development pipeline, from target identification through lead optimization and clinical stages, executing in days the computational analysis that otherwise takes specialist teams months. iollo also offers a direct-to-consumer metabolomics blood test that measures 600-plus metabolites to give individuals a molecular-level view of their health.
Business model
Enterprise R&D platform sold to pharma and biotech organizations, plus a direct-to-consumer blood test purchased individually.
Go-to-market
Pharma and biotech R&D teams access Quinn through a white-glove enterprise engagement with a scheduled demo; individual consumers purchase the metabolomics blood test directly through the iollo website.
From the Y Combinator listing
Building Quinn, an AI scientist accelerating pharma/biotech R&D
iollo is building Quinn, an AI scientist that automates the entire drug development lifecycle, from target discovery to commercial strategy. Quinn synthesizes scientific, clinical, and market data to execute complex R&D workflows in hours that typically take pharma teams years.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 4
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works